Subscribe to RSS
DOI: 10.1055/s-0038-1665317
Effect of Cyclic AMP and Cyclic GMP on Thromboplastin (Factor III) Synthesis in Human Monocytes In Vitro
Publication History
Received 24 May 1983
Accepted 26 August 1983
Publication Date:
18 July 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/198304/lookinside/thumbnails/10-1055-s-0038-1665317-1.jpg)
Summary
Human monocytes in vitro respond to various agents (immune complexes, lectins, endotoxin, the divalent ionophore A 23187, 12-0-tetradecanoyl-phorbol 13-acetate [TPA], purified protein derivative [PPD] of Bacille Calmette-Guerin) with an increased synthesis of the protein component of thromboplastin. The effect of cyclic AMP and cyclic GMP on this response has been studied. Dibutyryl-cyclic AMP, prostaglandin E1 and the phosphodiesterase inhibitors 3-butyl-1-methyl-xanthine (MIX) and rac -4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (Ro 201724), separately and in combination have a pronounced inhibitory effect on the response to immune complexes and PPD, and a moderate effect on the response to endotoxin and lectins. The effect on TPA response and on the response to A 23187 was slight. Dibutyryl-cyclic GMP (1 mM) gave a slight inhibition of the TPA arid IC response, but had essentially no effect on the response to other inducers. The intracellular cAMP level increased when monocytes were incubated with IC, TPA or A 23187 followed by a decrease to basal levels within 1-2 hr, whereas lectin (PHA) and PPD did not induce such changes. The cAMP response to endotoxin varied. Stimulation with IC induced an increase in monocyte cGMP levels, whereas the other stimulants did not cause such changes.
-
References
- 1 Prydz H, Allison AC, Schorlemmer HU. Further link between complement activation and blood coagulation. Nature 1977; 270: 173
- 2 Rothberger H, Zimmermann TS, Spiegelberg HL, Vaughan JH. Leukocyte procoagulant activity. Enhancement of production in vitro by IgG and antigen-antibody complexes J Clin Invest 1977; 59: 549-557
- 3 Prydz H, Lyberg T, Deteix P, Allison AC. In vitro stimulation of tissue thromboplastin (factor III) activity in human monocytes by immune complexes and lectins. Thiromb Res 1979; 15: 465-474
- 4 Rivers RP A, Hathaway WE, Weston WL. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 1975; 30: 311-316
- 5 Prydz H, Allison AC. Tissue thromboplastin activity of isolated human monocytes. Thromb Haemostas 1978; 39: 582-591
- 6 Lyberg T, Prydz H. Lectin stimulation of tissue thromboplastin activity in human monocytes in vitro. Thromb Haemostas 1980; 42: 1574-1579
- 7 Lyberg T, Prydz H. Phorbol esters induce synthesis of thromboplastin activity in human monocytes. Biochem J 1981; 194: 699-706
- 8 Prydz H, Lyberg T. Effect of some drugs on thromboplastin (factor III) activity of human monocytes in vitro. Biochem Pharm 1980; 29: 9-14
- 9 Bjørklid E, Storm E, Prydz H. The protein component of human brain thromboplastin. Biochem Biophys Res Commun 1973; 55: 969-976
- 10 Bjørklid E, Storm E. Purification and some properties of the protein component of tissue thromboplastin from human brain. Biochem J 1977; 165: 89-96
- 11 Prydz H, Lyberg T. Tissue thromboplastin - molecular and cellular biology. In: Protides of the Biological Fluids. Peeters H. (ed) Pergamon Press; 1980. 28 241-244
- 12 Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. J Clin Lab Invest 1968; 21 (suppl) (Suppl. 97) 77
- 13 Yam LT, Li CY, Crosby WH. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 1971; 55: 283-290
- 14 Bjørklid E, Giercksky KE, Prydz H. An immunoradiometric assay for factor III (tissue thromboplastin). Br J Haematol 1978; 39: 445-458
- 15 Hvatum M, Prydz H. Studies on tissue thromboplastin. I. Solubiliza-tion with sodium deoxycholate. Biochim Biophys Acta 1966; 130: 92-101
- 16 Markwell MA K, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in mem-brane and lipoprotein samples. Anal Biochem 1978; 87: 206-210
- 17 Fleck A, Munro HN. The precision of ultraviolet absorption measurements in the Schmidt-Tannhauser procedure for nucleic acid estimation. Biochim Biophys Acta 1962; 55: 571-583
- 18 Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of DNA. Biochem J 1956; 62: 315-323
- 19 Skomedal T, Grynne B, Osnes JB, Sjetnan E, Øye I. A radioim-munoassay for cyclic AMP (cAMP) obtained by acetylation of both unlabeled and labeled (3H-cAMP) ligand, or of unlabeled ligand only. Acta Pharmacol Toxicol 1980; 46: 200-204
- 20 Gordon S, Todd J, Cohn ZA. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med 1974; 139: 1228-1248
- 21 Gianetto R, de DuveC. Comparative study of the binding of acid phosphatase, β-glucuronidase and cathepsin by rat liver particles. Biochem J 1955; 59: 433-438
- 22 Kirkeby K, Prydz H. Lactic dehydrogenase activity in pleural and peritoneal effusions. Scand J Clin Lab Invest 1959; 11: 185-189
- 23 Whitfield JF, Macmanus JP, Braceland BM, Gillan DJ. The influence of calcium on the cyclic AMP-mediated stimulation of DNA synthesis and cell proliferation by prostaglandin E1 . J Cell Physiol 1971; 79: 353-362
- 24 Gemsa D, Steggemann L, Till G, Resch K. Enhancement of the PGE1 response of macrophages by concanavalin A and colchicine. J Immunol 1977; 119: 524-529
- 25 Samuelson B, Granstrøm E, Green K, Hamberg M, Hammarstrøm S. Prostaglandins. Ann Rev Biochem 1975; 44: 669-695
- 26 Beavo JA, Rogers NL, Crofford OB, Hardman JG, Sutherland EW, Newman EV. Effect of xanthine derivatives on lipolysis and on adenosine 3’,5’-monophosphate diesterase activity. Mol Pharmacol 1970; 6: 597-603
- 27 Gallin JI, Sandler JA, Clyman RI, Mangianello VC, Vaughan M. Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion. J Immunol 1978; 120: 492-496
- 28 Stoic V. Stimulatory effect of ionophores on adenosine 3’, 5’-monophosphate content in human mononuclear leukocytes. Biochem Pharmacol 1980; 29: 1991-1994
- 29 Bromberg Y, Pick E. Activation of macrophage adenylate cyclase by stimulants of the oxidative burst and by arachidonic acid - two distinct mechanisms. Cell Immunol 1981; 61: 90-103
- 30 Pick E, Keisari Y, Bromberg Y, Freund M. Effect of tumor promoters in immunological systems - the macrophage as a target cell for the action of phorbol esters. In Symposium on cocarcinogenesis of tumor promotors. Castle of Elmau, D-8101 Klais/Bavaria; FRG: 1980. Abstr 27
- 31 Grunspan-Swirsky A, Pick E. Facilitation of adenylate cyclase stimu-lation in macrophages by lectins. Cell Immunol 1979; 45: 415-427
- 32 Gemsa D, Woo C, Webb D, Fundenberg H, Schmid R. Erythrophagocytosis by macrophages: suppression of heme oxygenase by cyclic AMP. Cell Immunol 1975; 15: 21-36
- 33 Hilz H, Kaukel E, Wiegers U, Fuhrmann U. Basal cAMP in HeLa cells is protected from phosphodiesterase and does not turn over. Biochem Biophys Res Commun 1975; 64: 519-527
- 34 Takemoto DJ, Lee WN P, Kaplan SA, Appleman MM. Cyclic AMP phosphodiesterase in human lymphocytes and lymphoblasts. J Cycl Nucl Res 1978; 4: 123-132
- 35 Lehnert S. Changes in morphology and cell cycle traverse induced in CHO cells by methyl isobutyl xanthine. Exp Cell Res 1979; 121: 383-394
- 36 Weissmann G, Dukor P, Zurier RB. Effect of cyclic AMP on release of lysosomal enzymes from phagocytes. Nature New Biol 1971; 231: 131-135
- 37 Zurier RB, Hoffstein S, Weissmann G. Mechanisms of lysosomal enzyme release from human leukocytes. I. Effect of cyclic nucleotides and colchicine. J Cell Biol 1973; 58: 27-41
- 38 Weissmann G, Goldstein I, Hoffstein S. Prostaglandins and the modulation by cyclic nucleotides of lysosomal enzyme release. Adv Prost Thromb Res 1976; 2: 803-814
- 39 Rosen N, Schneck J, Bloom BR, Rosen OM. Inhibition of plasminogen activator secretion by cyclic AMP in a macrophage-like cell line. J Cycl Nucl Res 1978; 5: 345-358
- 40 Block LH, Aloni B, Biemesderfer D, Kashgarion M, Bitensky M. Macrophage migration inhibition factor: interactions with calcium, magnesium and cAMP. J Immunol 1978; 121: 1416-1421
- 41 Droller M, Schneider M, Perlmann P. A possible role of prostaglan-dins in the inhibition of natural and antibody dependent cell mediated cytotoxicity against tumor cells. Cell Immunol 1978; 39: 165-177
- 42 Schultz R, Pavlidis N, Stoychov J, Chirigos M. Prevention of macrophage tumoricidal activity by agents known to increase cellular cyclic AMP. Cell Immunol 1979; 42: 71-78
- 43 Vassalli JD, Hamilton J, Reich E. Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors and cyclic nucleotides. Cell 1976; 8: 271-281
- 44 Bourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM. Modulation of inflammation and immunity by cyclic AMP. Science 1974; 184: 19-28